Análise Estatística

Todos os valores nas figuras e no texto são expressos como média  desvio padrão da média das n observações (standard error of the mean). Para os estudo in vitro as tabelas são representativas de pelo menos três experiências realizadas em diferentes condições experimentais. No ensaio do ácido acético, os resultados foram analizados pelo método one-way ANOVA seguido pelo teste t de Dunnet para comparações múltiplas; as diferenças entre os valores do teste e os valores de controle foram considerados estatisticamente significativos quando p0,05. No ensaio edema de pata induzido por carragenina, as diferenças entre os valores do teste e os valores de controle foram considerados estatisticamente significativos quando p0,05.*_{p0,0, **p0,01 e ***p0,001 de acordo com o teste} de Duncan.

Nos ensaios in vitro (actividade da SIRT1 e produção de TNF-) foram considerados significativos valores de p inferiores a 0,05 e as médias dos grupos individuais foram comparadas com o teste t de Student.

I.5 REFERÊNCIAS

1 _{Weese, T.L., Bohs, L. (2007) A three-gene phylogeny of the genus Solanum (Solanaceae), Systematic Botany,}

32(2), 445-463.

2 _{Evans, W., Somanabandhu, A. (1982) Nitrogen-containing non-steroidal secondary metabolites of Solanum,}

Cyphomandra, Lycianthes and Maragaranthus, Phytochemistry, 19, 2351-2356.

3

Nakamura, T., Komori, C., Lee, Y.Y., Hashimoto, F., Yahara, S., Nohara, T., Ejima, A. (1996) Cytotoxic activities of

Solanum steroidal glycosides, Biol. Pharm. Bull., 19, 564-566.

4

Jain, R., Sharma, A., Gupta, S., Sarethy, I.P., Gabrani, R. (2011) Solanum nigrum: Current perspectives on

therapeutical properties, Alternative Medicine Review, 16, 78-85.

5 _{Vlachojannis, J.E., Cameron, M., Chrubasik, S. (2010) Medicinal use of potato-derived products: a systematic}

review, Phytother. Res., 24, 159-162.

6 _{Ohno, M., Ono, M., Nohara, T. (2011) New solanocapsine-type tomato glycoside from ripe fruit of Solanum}

lycopersicum, Chem. Pharm. Bull., 59(11), 1403-1405.

7 _{Lu, Y., Luo, J., Kong, L. (2011) Steroidal alkaloid saponins and steroidal saponins from Solanum surattense,}

Phytochemistry, 72, 668-679.

8 _{Ono, M., Nishimura, K., Suzuki, K., Fukushima, T., Igoshi, K., Yoshimitsu, H., Ikeda, T., Nohara, T. (2006) Steroidal}

glycosides from the underground parts of Solanum sodomaeum, Chem. Pharmacol. Bull., 54(2), 230-233.

9 _{Usubillaga, A., Aziz, I.,Tettamanzi, M.C., Waibel, R., Achenbach, H. (1997) Steroidal alkaloids from Solanum}

sycophanta, Phytochemistry, 44, 537-543.

10 _{Sun, L.X., Qi, W., Yang, H.Y., Jia, Y.R. (2011) Nitrogen-containing compounds from Solanum lyratum Thunb,}

Biochem. System. Ecol., 39, 203-204;

11 _{Lorenzi, H., Matos, F.J.A. (2002) Plantas Medicinais no Brasi,nativas e exóticas. Instituto Plantarum de Estudos}

da Flora Ltda, São Paulo, p. 459

12 _{Rodrigues, V.E.G., Carvalho, D.A. (2001) Levantamento etnobotânico de plantas Medicinais no domíniodo}

cerrado na região do Alto Rio Grande-Minas Gerais, Revista de Ciência e Agrotecnologia, 25, 102-123.

13 _{Araújo, C.E.P., Rodrigues, R. F. O., Oliveira, F., Schreiner, L. (2002) Análise preliminar da atividade}

antiulcerogénica do extrato hidroalcoólico de Solanum cernuum Vell., Acta Farm. Bonaerense, 21(4), 283-286.

14 _{Alves, T.M.A., Labanca, L., Stehmann, J.R., Zani, C.L. (2006) Chemical constituents of the water calyx of}

(2007) Morphological, anatomical, macro and micromolecular markers for Solanum cernuum identification, Braz. J. Pharmacognosy, 17, 542-548.

16 _{Hanahan, D., Weinberg, R.A. (2000) The hallmarks of cancer, Cell, 100, 57-70.}

17 _{Hanahan, D., Weinberg, R.A. (2011) The hallmarks of cancer: the next generation, Cell, 144, 646-674.} 18 _{Kinzler, K.W., Vogelstein, B. (1996) Lessons from hereditary colorectal cancer, Cell, 87, 159-170.}

19 _{Rakoff-Nahoum, S., (2006) Why cancer and Inflammation?, Yale Journal of Biology and medicine, 79, 123-130.} 20

Hussain, S.P., Harris, C.C. (2007) Inflammation and cancer: an ancient link with novel potentials, Int. J. Cancer, 121, 2373-2380.

21 _{Balkwill, F., Mantovani, A. (2001) Inflammation and cancer: back to Virchow?, Lancet, 357, 539-545.}

22 _{Schetter, A.J., Heegaard, N.H.H., Harris, C.C. (2010) Inflammation and cancer: interweaving microRNA, free}

radical, cytokine and p53 pathways, Carcinogenesis, 31(1), 37-49.

23 _{Schottenfeld, D., Beebe-Dimmer, J. (2006) Chronic inflammation: a common and important factor in the}

pathogenesis of neoplasia, CA Cancer J. Clin., 56, 69-83.

24 _{Matsuzaki, K., Murata, M., Yoshida, K., Sekimoto, G., Uemura, Y., Sakaida, N., Kaibori, M., Kamiyama, Y.,}

Nishizawa, M., Fujisama, J., Okazaki, K., Seki, T. (2007) Chronic inflammation associated with hepatis C virus

infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma, Hepatology, 46, 48-57.

25 _{Philpott, M., Ferguson, L.R. (2004) Immunonutrition and cancer, Mutat. Res., 551, 29-42.}

26 _{Itzkowitz, S.H., Yio, X. (2004) Inflammation and cancer IV. Colorectal in inflammatory bowel disease: the role of}

inflammation, Am. J. Physiol.Gastrointest. Liver Physiol., 287: G7-G17.

27 _{Eaden, J. Abrahms, K., Ekbom, A. Jackson, E., Mayberry, J. (2000) Colorectal cancer prevention in ulcerative}

colitis: a case-control study, Aliment Pharmacol. Ther., 14, 145-153.

28 _{Munger, K., Howley, P.M. (2002) Human Papilloma virus immortalization and transformation functions, Virus}

Res., 89, 213-228.

29 _{Kundu, J.K., Surh, Y.J. (2005) Breaking the relay in deregulated cellular signal transduction as a rationale for}

chemoprevention with anti-inflammatory phytochemicals, Mutat. Res., 591, 123-146.

30 _{Kundu, J.K., Surth, Y.J. (2008) Inflammation: Gearing the journey to cancer, Mutation Res., 659, 15-30.}

S.S., Moss, S.F., Hacker, A., Wang, Y., Casero Jr, R.A., Wilson, K.T. (2004) Spermine oxidation induced by

Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis, Cancer Res., 64,

8521-8525.

33 _{Jaiswal, M., LaRusso, N.F., Burgart, I.J., Gores, G.J. (2000) Inflammatory cytokines induce DNA damage and}

inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism, Cancer Res., 60, 184-190.

34 _{Pinlaor, S., Sripa, B., Ma, N., Hiraku, Y., Yongvanit, P., Wongkham, S., Pairojkui, C., Bhudhisawasdi, V., Oikawa,}

S., Murata, M., Semba, R., Kawanishi, S. (2005) Nitrative and oxidative DNA damage in intrahepatic

cholangiocarcinoma patients in relation to tumor invasion, World J. Gastroenterol., 11, 4644-4649.

35 _{Bartsch, H., Nair, J. (2005) Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for}

chemoprevention of inflammation-driven malignancies, Mutat. Res., 591, 34-44.

36 _{Ohshima, H., Tazawa, H., Sylla, B.S., Sawa, T. (2005) Prevention of human cancer by modulation of chronic}

inflammatory processes, Mutation Res. 591, 110-122.

37 _{Pikarski, E., Porta, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S.,}

Galun, E., Ben-Neriah, Y. (2004) NF-kappa functions as a tumour promoter in inflammation-associated cancer, Nature, 23(7007), 2461-466.

38 _{Ghosh, S., Hayden, M.S. (2008) New regulators of NF-kB in inflammation, Nat. Rev, 8, 837-848.}

39 _{Onizawa, M., Nagaishi, T., Kanai, T., Nagano, K., Oshima, M.S., Nemoto, Y., Yoshioka, A., Totsuka, T., Okamoto,}

R., Nakamura, T., Sakamoto, N., Tsuuchia, K., Aoki, K., Yagita, H., Watanabe, M. (2009) Signaling pathway via

TNF-/NF-kB inj intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis, Am. J.

Physiol. Gastrointest. Liver Physiol., 296, G850-G859.

40 _{Yoshizaki, T. Milne, J., Imamura, T., Schenk, S., Sonoda, N., Babendure, J., Lu, J., Smith, J., Jirousek, M., Olefsky,}

J. (2009) SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Molecular and Cellular Biology, 29, 1363-1374.

41 _{Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., Mayo, M.W. (2004) Modulation of}

NF-B dependent transcription and cell survival by the SIRT1 deacetylase, EMBO J., 2369-2380.

42 _{Yoshizaki, T., Schenk, S., Imamura, T., Babendure, J., Sonoda, N., Bae, E.J., Oh, D.Y., Lu, M., Milne, J.C.,}

Westphal, C., Bandyopadhyay, G., Olefsky, J. (2010) SIRT1 inhibits inflammatory pathways and modulates insulin

sensitivity Am. J. Phissiol.Endocrinol.Metab., 298, E419-E428.

43